Viewing Study NCT03345134


Ignite Creation Date: 2025-12-25 @ 2:29 AM
Ignite Modification Date: 2026-01-08 @ 12:42 AM
Study NCT ID: NCT03345134
Status: NOT_YET_RECRUITING
Last Update Posted: 2017-11-17
First Post: 2017-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab in Combination With BCG After Ablation in Patients With UUTTCC Without Nephroureterectomy
Sponsor: Shaheen Alanee
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module